Predicting Choroidal Melanoma Regression after Brachytherapy
After brachytherapy, some choroidal melanomas regress faster than others. Several studies suggest that these tumors are more likely to metastasize than those that regress slowly. Not all authors support this view, some reporting no correlation between tumor regression and monosomy 3, which is highly lethal.1 More research is needed to determine whether tumor regression rate after brachytherapy predicts metastasis.
Source: Ophthalmology - Category: Opthalmology Authors: Bertil Damato Tags: Commentary Source Type: research
More News: Brachytherapy | Eye Cancers | Melanoma | Opthalmology | Skin Cancer | Study | Uveal Melanoma